Clinical Trial Update: Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD) [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating the safety and efficacy of oral HX9428 tablets in patients with wet age-related macular degeneration…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• HX9428

Snippet

Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd. | Conditions: Wet Age-related Macular Degeneration (AMD) | Phase 1, Phase 2 | Status: RECRUITING